Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Mesa Laboratories (MLAB) Equity Average (2016 - 2025)

Historic Equity Average for Mesa Laboratories (MLAB) over the last 15 years, with Q4 2025 value amounting to $182.6 million.

  • Mesa Laboratories' Equity Average rose 1365.72% to $182.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $182.6 million, marking a year-over-year increase of 1365.72%. This contributed to the annual value of $152.6 million for FY2025, which is 4335.9% down from last year.
  • Mesa Laboratories' Equity Average amounted to $182.6 million in Q4 2025, which was up 1365.72% from $175.5 million recorded in Q3 2025.
  • Mesa Laboratories' 5-year Equity Average high stood at $409.5 million for Q1 2021, and its period low was $148.1 million during Q2 2024.
  • Its 5-year average for Equity Average is $306.8 million, with a median of $383.9 million in 2022.
  • Per our database at Business Quant, Mesa Laboratories' Equity Average skyrocketed by 8032.82% in 2021 and then plummeted by 6209.42% in 2024.
  • Mesa Laboratories' Equity Average (Quarter) stood at $397.9 million in 2021, then decreased by 4.31% to $380.7 million in 2022, then grew by 3.85% to $395.4 million in 2023, then crashed by 59.37% to $160.6 million in 2024, then increased by 13.66% to $182.6 million in 2025.
  • Its Equity Average stands at $182.6 million for Q4 2025, versus $175.5 million for Q3 2025 and $166.2 million for Q2 2025.